Celmatix Therapeutics

📍 New York, United States🗓 Founded 2009👥 24 employees💰 Last funded Mar 2019
Biotechnology Research🌐 celmatix.com
Website LinkedIn
Celmatix Therapeutics is a preclinical-stage women’s health biotech focused on advancing groundbreaking therapeutics for women’s health. With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging, an oral FSH for infertility, and a JNK inhibitor program for endometriosis, Celmatix Therapeutics is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in women’s health. For more information, visit the company’s website at www.celmatix.com.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Celmatix Therapeutics?
Celmatix Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Celmatix Therapeutics last raise funding?
The most recent investment in Celmatix Therapeutics recorded on gritt.io was in March 2019.
When was Celmatix Therapeutics founded?
Celmatix Therapeutics was founded in 2009.
What industry is Celmatix Therapeutics in?
Celmatix Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Celmatix Therapeutics based?
Celmatix Therapeutics is headquartered in New York, United States.